Title: Global Biochip Market to reach $5.6 Billion by 2015
1MarketsandMarkets Presents
Global Biochip (DNA Microarrays, Lab-on-Chip,
Protein Microarrays, Tissue Cell Arrays) Market
to reach 5.6 Billion by 2015
2- The Biochips Market (DNA Microarrays,
Lab-on-Chip, Protein Microarrays, Tissue Cell
Arrays) Trends Global Forecast (2010-2015)
analyzes the biochip market by types and
applications and studies the major market
drivers, restraints, opportunities, and market
trends for biochip market in North America,
Europe, Asia, and Rest of the World. - Browse market data tables and in-depth TOC on
"Biochips Market (DNA Microarrays, Lab-on-Chip,
Protein Microarrays, Tissue Cell Arrays) Trends
Global Forecast (2010-2015). - http//www.marketsandmarkets.com/Market-Reports/bi
ochips-advanced-technologies-and-global-market-54.
html - Early buyers will receive 10 customization on
reports.
3- Biochips were developed and commercialized in the
eighties. Since then, market has offered
tremendous growth and hence seen an influx of
players vying fiercely for a share of this
market. The global biochips market is studied by
the types and key applications. It was valued at
2.6 billion in 2010 and is expected to reach
5.6 Billion by 2015 - growing at a CAGR of 16.7.Major players in this
market include Affymetrix, Inc. (U.S.), Illumnia,
Inc. (U.S.), Agilent Technologies, Inc. (U.S.),
Roche NimbleGen (U.S.), Sequenom Inc, (U.S.),
Luminex Corporation (U.S.), Bio-Rad Laboratories
(U.S.), Biacore Life Sciences by GE Healthcare
(Sweden), EMD Millipore (U.S.), Life Technologies
(U.S.), Perkin Elmer (U.S.), Caliper Life
Sciences (U.S.), Fluidigm Corporation (U.S.),
Cepheid (U.S.), Epoch Biosciences (U.S.), US
Biomax (U.S.), Sigma Aldrich (U.S.), Biochain
Institute, Inc. (U.S.), Origene (U.S.), Super
BioChips (South Korea ), and IsuAbxis Co Ltd
(Seoul, Korea). - New product launches and agreements and
collaborations are the two main strategies
adopted by the players to stay competitive in
this market.
4- The major applications in the market driving its
growth in future include cancer diagnosis and
treatment, expression profiling, and diagnostics
since early detection of disease and targeted
treatment options are still the unmet need of
this market. There were 12.3 million new cases of
cancer worldwide in 2007 and about 7.6 million
deaths. These figures are estimated to rise up to
16 million new cancer diagnoses and about 10
million deaths by 2020 according to WHO
American Cancer Society.
5Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets
6About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.